CancerNetwork Members: Login | Register
 
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
PATIENTS
NURSES
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

Oncology NEWS International. Vol. 16 No. 5
 

Removing Chemotherapy Bags From IV Spikes Is Unsafe

May 1, 2007

BOSTON—In a Quality Indicator (QI) project, oncology nurses at M.D. Anderson Cancer Center showed that changing intravenous (IV) bags of hazardous drugs (such as chemotherapy agents) is an unsafe procedure with nearly universal contamination of the nurses' gloves, gowns, and drapes. Further, the nurses found that hydrophobic IV tube caps meant to reduce accidental drug exposure actually increase it. Rosanne Arlington, RN, MSN, CNS, OCN, ONC, and her colleagues reported the findings at the Oncology Nursing Society 31st Annual Congress last year (abstract 23).

The studies, which used a fluorescent dye to track leakage, also showed little risk of environmental contamination with either conventional spiking and priming techniques or the PhaSeal closed system (Carmel Pharma, Göteborg, Sweden), although the PhaSeal system may provide some protection against accidentally spiking through a bag.

UV Light Shows Contamination

Five experienced oncology nurses participated in the QI project; each nurse primed IV tubings with normal saline, then spiked 20 conventional 250 mL IV bags containing normal saline and a fluorescein(Drug information on fluorescein) dye (10 with PhaSeal ports and 10 without). Tubing, IV bags, gloves, gowns, and drapes were inspected with UV light before and after spiking, as well as during the spiking, priming, and initial opening of the roller clamps, to simulate chemotherapy administration, Ms. Arlington said.

No contamination was observed with either approach during priming and spiking, but changing bags was another story. "With each removal of an IV bag from the IV tubing device, there was splattering and environmental contamination," Ms. Arlington said. "Our findings indicate that removal of an IV bag containing hazardous drug from an IV spike is inherently unsafe and should be avoided." All such bags should be removed with the tubing intact.

She noted that this has posed a dilemma at M.D. Anderson Cancer Center for some study protocols calling for intra-arterial chemotherapy. The solution, Dr. Arlington said, has been custom-made IV tubing sets.

Hydrophobic Filters a Problem

The team also looked at the safety of methods used to prime tubing when chemotherapy dosing is based on pharmacokinetics. A nurse and a pharmacist primed 50 IV tubings with fluorescein solution to within ° to Ω inch of the end of the tubing, then capped 25 of the tubings with hydrophobic filters and 25 with standard IV caps. In 22 of the 25 tubings with hydrophobic caps, solution was drawn to the end of the tubing when the caps were removed to attach tubing to IV ports. The solution then hung as a droplet from the tubing tip and smeared onto gloves, drapes, and connection ports. Only 3 tubings closed with conventional IV caps had similar contamination.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

  • Bladder Cancer
  • Bone Metastases
  • Breast Cancer
  • CML
  • Colorectal Cancer
  • End-of-Life
  • GIST
  • Genetics Genomics
  • Gynecologic Cancers
  • Head & Neck Cancer
  • Integrative Oncology
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Nausea & Vomiting
  • Palliative Care
  • Pancreatic Cancer
  • Practice Management
  • Practice & Policy
  • Prostate Cancer
  • RCC
  • Skin Cancer
  • Triple-Negative Breast
  • Testicular Cancer


More Topics 

 
PUBLICATIONS
ONCOLOGY Journal ONCOLOGY Nurse Edition Journal Cancer Management: A Multidisciplinary Approach

ONCOLOGY:
Perspectives on Best Practices

ONCOLOGY:
Nurse Edition

CANCER
MANAGEMENT
:
A Multidisciplinary
Approach


 
IMAGE IQ

Other than surgical interventions, which medication might be most appropriate for this patient?

A 68-year-old woman presented with a mass on the scalp. An incisional biopsy of the scalp mass and an excisional biopsy of the lymph node both revealed basal cell carcinoma.

 

More Image IQs:

 

 
FROM PHYSICIANS PRACTICE
'What They Should Really Teach in Medical School'
Julie Schopps, MD , February 6, 2012
The North Carolina-based pediatrician weighs in on why she thinks the real learning doesn't take place until students are out of the classroom.
Improve EHR Systems by Rethinking Medical Billing
Daniel Essin, MA, MD, February 6, 2012
Separating billing-related data from other clinical documentation and transmitting it to a billing system is not difficult …no matter how the charting is done.
Keeping Your Medical Practice’s Accounts Receivable on Track
P.J. Cloud-Moulds, February 4, 2012
Here are the minimum reports you should be running to keep an eye on your practices A/R.
Healthcare Providers Play Crucial Role in Helping Victims of Abuse
Stephen Hanson, PA-C , February 3, 2012
I would urge each and every one of you to be familiar with the warning signs of abuse, and the resources available to you all as healthcare providers.
Protecting Your Medical Practice's Data
Marisa Torrieri, February 3, 2012
Here's the scoop on how to implement a good data-backup plan at your office.
 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Management of Brain Metastases: Neurosurgical Considerations
  • Head and Neck Tumors
  • Optimizing Outcomes of Advanced Prostate Cancer: Drug Sequencing and Novel Therapeutic Approaches
  • A 28-Year-Old Woman Presents With a Long-Standing History of Intermittently Painful “Bumps” on Both Her Shoulders and Upper Back
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • Ending the Shortage of Generic Oncology Drugs
  • Processed and Red Meat Consumption Linked to Slight Increase in Risk of Pancreatic Cancer
  • Younger Breast Cancer Patients Have More Adverse Quality of Life Issues
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • Could Aspirin Be a Viable Adjuvant Treatment for Cancer?
  • AL Amyloidosis: Who, What, When, Why, and Where
  • The Maze of PARP Inhibitors in Ovarian Cancer
  • The Circuitous Path of PARP Inhibitor Development in Epithelial Ovarian Cancer
  • Podcast: Dr. David Ahlquist on Advances in Colorectal Cancer Screening
  • Lung Cancer Screening: A New Era
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • When to Treat Myelodysplastic Syndromes
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • PSA Screening for Prostate Cancer Put Into Question By the U.S. Preventive Services Task Force
  • PSA Screening for Prostate Cancer Put Into Question By the U.S. Preventive Services Task Force
  • When to Treat Myelodysplastic Syndromes
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • Are We Ready for Neoadjuvant Therapy in Potentially Resectable Pancreatic Cancer?
  • Evolving Therapeutic Paradigms for Advanced Prostate Cancer
Click here to subscribe to our newsletter
 
JOB LISTINGS

Post a job

Powered by SearchMedica Jobs



CancerNetwork on Facebook

 

CancerNetwork | CME LLC | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2012 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy